![]() ![]() Ĭucchiara B, Messe S, Sansing L, Kasner S, Lyden P (2008) Hematoma growth in oral anticoagulant related intracerebral hemorrhage. (09)60503-1Ĭreutzfeldt CJ, Weinstein JR, Longstreth WT, Becker KJ, McPharlin TO, Tirschwell DL (2009) Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. Ĭollins R, Peto R, Hennekens C, Doll R, Bubes V, Buring J, Dushkesas R, Gaziano M, Brennan P, Meade T, Rudnicka A, Hansson L, Warnold I, Zanchetti A, Avanzini F, Roncaglioni MC, Tognoni G, Chown M, Baigent C, Barton I, Baxter A, Bhala N, Blackwell L, Boreham J, Bowman L, Buck G, Emberson J, Godwin J, Halls H, Holland L, Kearney P, Reith C, Wilson K, Patrono C (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Cerebrovasc DisĬhen C-J, Ding D, Buell TJ, Testai FD, Koch S, Woo D, Worrall BB (2018) Restarting antiplatelet therapy after spontaneous intracerebral hemorrhage. īrouwers HB, Greenberg SM (2013) Hematoma expansion following acute intracerebral hemorrhage. īolliger D, Seeberger MD, Tanaka KA (2012) Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). īlais N, Pharand C, Lordkipanidzé M, Sia YK, Merhi Y, Diodati JG (2009) Response to aspirin in healthy individuals. (16)30392-0īaschin M, Selleng S, Zeden JP, Westphal A, Kohlmann T, Schroeder HW, Greinacher A, Thiele T (2017) Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage. What is clearly evident from the present survey is the considerable variability in neurosurgical care for antiplatelet patients it is reasonable to assume that this scenario reflects the paucity of evidence regarding this issue.īaharoglu MI, Cordonnier C, Salman RA-S, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, Nederkoorn PJ, de Haan RJ, Roos YB, Investigators PATCH (2016) Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. There is a considerable lack of consensus regarding management of antiplatelet therapy in neurosurgery, with critical impact on patient’s treatment. The present paper was designed by following each question posed in the survey by a brief discussion on literature data. This survey was conducted including 129 neurosurgery units in Italy. ![]() In this paper, we present the results of an Italian survey focused on the management neurosurgical patient under antiplatelet therapy and, for any item of the investigation, the relative advices coming from literature. Currently, the management of neurosurgical patients receiving this type of therapy continues to be a problem of special importance. The use of antiplatelet medication is widespread as reducing risk of death, myocardial infarction, and occlusive stroke. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |